# 4D Molecular Therapeutics, Inc.: Form 8-K, filed May 20, 2021

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: 8-K
- Filed: 2021-05-20
- Accepted by EDGAR: May 20, 2021, 16:06 ET
- Period: 2021-05-17
- Accession: 0001564590-21-029069
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000156459021029069/fdmt-8k_20210517.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000156459021029069/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000156459021029069/fdmt-8k_20210517.htm

Filed May 20, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-029069. Last ingested by Listed: Nov 13, 2026, 16:07 ET. No prices; not investment advice.
